AIM: To determine the concentration of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases. METHODS: Concentrations of human neutrophil peptides (HNPs) 1-3, the major forms of alpha-defensins, and human beta-defensin (HBD)-1 and HBD-2 were measured by radioimmunoassay in plasma and gastric juice of 84 subjects, consisting of 54 Helicobacter pylori-infected and 30 uninfected subjects. They included 33 patients with chronic gastritis (CG), 12 with gastric ulcer (GU), 11 with duodenal ulcer (DU), 11 with benign gastric polyp (BGP) and 16 with normal mucosa (N group) on upper endoscopy. Plasma pepsinogen I and II levels, biomarkers for gastric mucosal inflammation and atrophy, were also measured. RESULTS: Gastric juice HNPs 1-3 levels in patients with CG, GU and BGP were significantly higher than those in patients with DU and N. Gastric juice HBD-2 concentrations in patients with CG and GU were significantly higher than those in the N group, but were significantly lower in DU patients than in GU patients. Gastric juice HBD-1 levels and plasma levels of these peptides were similar in the patient groups. Concentrations of gastric juice HNPs 1-3 and HBD-2 of in H pylori-infected patients were significantly different from those in uninfected subjects. HNPs 1-3 concentrations in gastric juice correlated negatively with plasma pepsinogen I levels and I/II ratios. HBD-2 levels in gastric juice correlated positively and negatively with plasma pepsinogen II concentrations and I/II ratios, respectively. CONCLUSION: HNPs 1-3 and HBD-2 levels in gastric juice are diverse among various gastrointestinal diseases, reflecting the inflammatory and atrophic events of the background gastric mucosa affected by H pylori.
AIM: To determine the concentration of alpha- and beta-defensins in gastric juice of patients with various gastroduodenal diseases. METHODS: Concentrations of human neutrophil peptides (HNPs) 1-3, the major forms of alpha-defensins, and humanbeta-defensin (HBD)-1 and HBD-2 were measured by radioimmunoassay in plasma and gastric juice of 84 subjects, consisting of 54 Helicobacter pylori-infected and 30 uninfected subjects. They included 33 patients with chronic gastritis (CG), 12 with gastric ulcer (GU), 11 with duodenal ulcer (DU), 11 with benign gastric polyp (BGP) and 16 with normal mucosa (N group) on upper endoscopy. Plasma pepsinogen I and II levels, biomarkers for gastric mucosal inflammation and atrophy, were also measured. RESULTS: Gastric juice HNPs 1-3 levels in patients with CG, GU and BGP were significantly higher than those in patients with DU and N. Gastric juice HBD-2 concentrations in patients with CG and GU were significantly higher than those in the N group, but were significantly lower in DU patients than in GU patients. Gastric juice HBD-1 levels and plasma levels of these peptides were similar in the patient groups. Concentrations of gastric juice HNPs 1-3 and HBD-2 of in H pylori-infectedpatients were significantly different from those in uninfected subjects. HNPs 1-3 concentrations in gastric juice correlated negatively with plasma pepsinogen I levels and I/II ratios. HBD-2 levels in gastric juice correlated positively and negatively with plasma pepsinogen II concentrations and I/II ratios, respectively. CONCLUSION: HNPs 1-3 and HBD-2 levels in gastric juice are diverse among various gastrointestinal diseases, reflecting the inflammatory and atrophic events of the background gastric mucosa affected by H pylori.
Authors: Y Hamanaka; M Nakashima; A Wada; M Ito; H Kurazono; H Hojo; Y Nakahara; S Kohno; T Hirayama; I Sekine Journal: Gut Date: 2001-10 Impact factor: 23.059
Authors: H Isomoto; Y Mizuta; K Inoue; T Matsuo; T Hayakawa; M Miyazaki; K Onita; F Takeshima; K Murase; I Shimokawa; S Kohno Journal: Scand J Gastroenterol Date: 1999-04 Impact factor: 2.423
Authors: T Hiratsuka; M Nakazato; Y Date; J Ashitani; T Minematsu; N Chino; S Matsukura Journal: Biochem Biophys Res Commun Date: 1998-08-28 Impact factor: 3.575
Authors: M Nakazato; K Shiomi; Y Date; S Matsukura; K Kangawa; N Minamino; H Matsuo Journal: Biochem Biophys Res Commun Date: 1995-06-26 Impact factor: 3.575
Authors: David J McGee; Alika E George; Elizabeth A Trainor; Katherine E Horton; Ellen Hildebrandt; Traci L Testerman Journal: Antimicrob Agents Chemother Date: 2011-04-04 Impact factor: 5.191
Authors: Sabine Nuding; Michael Gersemann; Yoshio Hosaka; Sabrina Konietzny; Christian Schaefer; Julia Beisner; Bjoern O Schroeder; Maureen J Ostaff; Katunori Saigenji; German Ott; Martin Schaller; Eduard F Stange; Jan Wehkamp Journal: PLoS One Date: 2013-09-11 Impact factor: 3.240